title: Neutrophil microvesicles resolve gout by inhibiting C5a-mediated priming of the inflammasome.
abstract: Gout is a highly inflammatory but self-limiting joint disease induced by the precipitation of monosodium urate (MSU) crystals. While it is well established that inflammasome activation by MSU mediates acute inflammation, little is known about the mechanism controlling its spontaneous resolution. The aim of this study was to analyse the role of neutrophil-derived microvesicles (PMN-Ecto) in the resolution of acute gout.
  
  
  
  PMN-Ecto were studied in a murine model of MSU-induced peritonitis using C57BL/6, MerTK(-/-) and C5aR(-/-) mice. The peritoneal compartment was assessed for the number of infiltrating neutrophils (PMN), neutrophil microvesicles (PMN-Ecto), cytokines (interleukin-1β, TGFβ) and complement factors (C5a). Human PMN-Ecto were isolated from exudates of patients undergoing an acute gouty attack and functionally tested in vitro.
  
  
  
  C5a generated after the injection of MSU primed the inflammasome for IL-1β release. Neutrophils infiltrating the peritoneum in response to C5a released phosphatidylserine (PS)-positive PMN-Ecto early on in the course of inflammation. These PMN-Ecto in turn suppressed C5a priming of the inflammasome and consequently inhibited IL-1β release and neutrophil influx. PMN-Ecto-mediated suppression required surface expression of the PS-receptor MerTK and could be reproduced using PS-expressing liposomes. In addition, ectosomes triggered the release of TGFβ independent of MerTK. TGFβ, however, was not sufficient to control acute MSU-driven inflammation in vivo. Finally, PMN-Ecto from joint aspirates of patients with gouty arthritis had similar anti-inflammatory properties.
  
  
  
  PMN-Ecto-mediated control of inflammasome-driven inflammation is a compelling concept of autoregulation initiated early on during PMN activation in gout.
authors.affiliation: Department of Biomedicine, University Hospital Basel, Basel, Switzerland Department of Medicine, University Hospital Basel, Basel, Switzerland.
authors.forename: Arun
authors.initials: A
authors.lastname: Cumpelik
authors.affiliation: Department of Rheumatology, University Hospital Basel, Basel, Switzerland.
authors.forename: Barbara
authors.initials: B
authors.lastname: Ankli
authors.affiliation: Department of Biomedicine, University Hospital Basel, Basel, Switzerland Department of Medicine, University Hospital Basel, Basel, Switzerland Department of Nephrology, University Hospital Regensburg, Regensburg, Germany.
authors.forename: Daniel
authors.initials: D
authors.lastname: Zecher
authors.affiliation: Department of Biomedicine, University Hospital Basel, Basel, Switzerland Department of Medicine, University Hospital Basel, Basel, Switzerland.
authors.forename: Jürg A
authors.initials: JA
authors.lastname: Schifferli
mesh_terms: D000208:Acute Disease; D000818:Animals; D055252:Cell-Derived Microparticles / Q000502:physiology* / Q000637:transplantation; D002478:Cells, Cultured; D015936:Complement C5a / Q000096:biosynthesis / Q000276:immunology*; D016207:Cytokines / Q000378:metabolism; D006073:Gout / Q000276:immunology / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D058847:Inflammasomes / Q000276:immunology / Q000378:metabolism / Q000502:physiology*; D008081:Liposomes / Q000378:metabolism; D008810:Mice, Inbred C57BL; D018375:Neutrophil Activation / Q000502:physiology; D020556:Neutrophil Infiltration / Q000502:physiology; D009504:Neutrophils / Q000502:physiology*; D010538:Peritonitis / Q000276:immunology / Q000473:pathology; D010718:Phosphatidylserines / Q000378:metabolism
chemical_list: D016207:Cytokines; D058847:Inflammasomes; D008081:Liposomes; D010718:Phosphatidylserines; D015936:Complement C5a
keywords: Cytokines; Gout; Inflammation